openPR Logo
Press release

The Biopharmaceutical Market to join the growth adsorption spectrum

12-09-2021 11:54 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Biopharmaceutical Market to join the growth adsorption

The Biopharmaceutical Market, in the next 10 years, is expected to substantiate. Hospital decision support solutions are being floated, and the status quo is expected to stay the same even going forward. Herein, value propositions are made to the society on the whole and patients in particular by the government, private insurance companies, and social security organizations working in unison. As such, the healthcare industry is expected to witness a good number of clinical outcomes in the forthcoming period.

According to a new market report published by Persistence Market Research “Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020”, the global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to grow at a CAGR of 9.4% from 2014 to 2020, to reach an estimated value of US$ 278 Bn by 2020.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/2827

Biopharmaceuticals are medicinal drugs, produced by isolation of the medicinal products from biological sources such as from animals, plants, humans and microorganisms, using biotechnological techniques such as recombinant DNA technology. They can also be produced using transgenic organisms, particularly animals and plants that have been genetically engineered to produce drugs. These drugs help in prevention and treatment of various diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, cardiovascular disease, anemia arising from chemotherapy, chronic renal failure, cancer, and diabetes.Company Profiles:

Pfizer, Inc.
F. Hoffmann-La Roche AG.
Johnson & Johnson Services, Inc.
Sanofi, Amgen Inc.
AbbVie Inc.
Merck & Co., Inc.
Biogen Idec.
Bayer AG.
Eli Lilly and Company.
Novartis AG GlaxoSmithKline Plc.
Bristol-Myers Squibb Company.
AstraZeneca PLC.
Abbott Laboratories.

Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com

Globally, the biopharmaceuticals market is witnessing significant growth due to increasing prevalence of chronic diseases, rising aging population, technological advancements in biopharmaceuticals, and increasing R&D investments. In addition, the capability of biopharmaceuticals to approach a particular target with high efficacy helps in the treatment of various chronic diseases and disorders. Biopharmaceuticals, such as monoclonal antibodies, hormones, cytokines, clotting factors, cell therapies, antisense drugs, recombinant insulin, and vaccines, have the potential to prevent, treat, and completely heal the diseases which are otherwise difficult to cure or have no available treatment. This, in turn, fuels growth of the biopharmaceuticals market. However, factors such as high costs of biopharmaceuticals, the risk of side–effects, and availability of low-cost biosimilars are restraining the growth of the global market for biopharmaceuticals. The global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to reach US$ 278 Bn by 2020 at a CAGR of 9.4% during the forecast period.

North America is the largest market for biopharmaceuticals. This is due to technological advancements in the region. The North America market for biopharmaceuticals was valued at US$ 64.7 Bn in 2014 and is expected to reach US$ 111.5 Bn by 2020 at a CAGR of 9.5% over the forecast period. In terms of type, monoclonal antibodies are the fastest growing segment. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have wide applications in the pharmaceutical industry.

For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/2827

One of the latest trends in the global biopharmaceuticals market is that of outsourcing, where biopharmaceutical companies are dependent on contract manufacturing organizations to produce a biopharmaceutical drug substance, which helps reducing investments for a new product launch.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/biopharmaceutical-market.asp

Contact us:
305 Broadway, 7th Floor
New York City, NY 10007 United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Biopharmaceutical Market to join the growth adsorption spectrum here

News-ID: 2491563 • Views:

More Releases from Persistence Market Research

Shunt Capacitor Market Valued at USD 1.2 Billion and Expected to Reach USD 1.8 Billion with a CAGR of 5.9 % Highlighting Growth Opportunities
Shunt Capacitor Market Valued at USD 1.2 Billion and Expected to Reach USD 1.8 B …
Shunt capacitors are crucial components in electrical power systems, designed to improve voltage stability, enhance power factor, and optimize energy efficiency. They play an essential role in industrial, commercial, and utility applications, providing cost-effective solutions to reduce energy losses and improve system reliability. The rising demand for stable and efficient power systems, coupled with increasing investments in smart grids and renewable energy integration, has propelled the growth of the global
Isobutyric Acid Market Outlook 2024 to 2031 From US$ 182.6 Million to US$ 304.9 Million with 7.6 % CAGR
Isobutyric Acid Market Outlook 2024 to 2031 From US$ 182.6 Million to US$ 304.9 …
Isobutyric acid is a valuable carboxylic acid widely utilized in the chemical industry for the production of esters, solvents, pharmaceuticals, and flavoring agents. Its versatility makes it a critical ingredient across multiple applications, ranging from food and beverages to cosmetics and industrial chemicals. As global industries increasingly shift toward high-performance chemicals and sustainable solutions, the demand for isobutyric acid has seen steady growth. The market for isobutyric acid is projected to
Ultra-High Molecular Weight Polyethylene Market to Reach US$4.74 Billion by 2031, Growing at 9.8% CAGR
Ultra-High Molecular Weight Polyethylene Market to Reach US$4.74 Billion by 2031 …
The global shift toward sustainability and reduced dependence on fossil fuels has placed renewable chemicals at the forefront of modern industrial transformation. Renewable chemicals, also known as bio-based chemicals, are derived from renewable biomass sources such as agricultural crops, waste materials, and microorganisms. They serve as sustainable alternatives to conventional petrochemicals used in a wide range of applications, from bio-plastics and solvents to detergents and pharmaceuticals. Growing environmental concerns, strict government
Critical Infrastructure Protection System Market to Reach US$198.2 Bn by 2032, Growing at 4.2 % CAGR
Critical Infrastructure Protection System Market to Reach US$198.2 Bn by 2032, G …
Critical infrastructure protection has become one of the most pressing priorities for governments, enterprises, and regulatory bodies around the world. As nations modernize and economies digitize, essential systems such as energy, transportation, water, communication, and healthcare increasingly depend on interconnected networks. While these systems enable efficiency and global connectivity, they also create vulnerabilities that expose vital infrastructure to risks such as cyberattacks, terrorism, and natural disasters. The rise of smart cities,

All 5 Releases


More Releases for Biopharmaceutical

Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031" The global Biopharmaceutical third-party logistics market
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030. The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial